| P/E (FY) | 131.2 | Sales (TTM) | $458.7M |
| Earnings (TTM) | $11.7M | ROE | 2.70% |
| Net Margin | 2.21% | ROIC | 3.93% |
| Debt / Equity | 0.48 | TD / EBITDA | 3.83 |
| EPS Growth 3Y | — | Sales Growth 3Y | 12.04% |
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. Its products include On-X prosthetic aortic and mitral heart valves, the On-X ascending aortic prosthesis, CarbonAid CO2 diffusion catheters, Chord-X ePTFE sutures, and pyrolytic carbon coating services. The company also offers a range of stent graft systems, including E-vita Open NEO, Arcevo, AMDS hybrid prosthesis, and the NEXUS endovascular systems for treating aortic vascular diseases.
| Market Cap | $1.34B | Trading Days | 1128 |
| 52W High | 48.25 |
| 52W Low | 19.16 |
| % Off High | −42.65% |
| YTD | −39.33% | 1Y | −12.35% |
| 3Y | 58.84% | Since incept. (ann.) | 9.76% |
North America 50% · Europe The Middle East And Africa Segments 34% · Asia Pacific 10% · Latin America 5%
| Ann. Volatility (1Y) | 54.00% | Ann. Volatility (3Y) | 43.75% |
| Sharpe (1Y) | 0.04 | Sharpe (3Y) | 0.58 |
| Max Drawdown (1Y) | −57.80% | Max Drawdown (3Y) | −57.80% |
| Beta (3Y, vs SPY) | 1.56 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.33B | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.28B | — |
| TNDM | TANDEM DIABETES CARE INC | $1.27B | — |
| ATEC | Alphatec Holdings, Inc. | $1.46B | — |
| INSP | Inspire Medical Systems, Inc. | $1.47B | 10.4 |
| IRMD | IRADIMED CORP | $1.20B | 53.9 |
| PRCT | PROCEPT BioRobotics Corp | $1.02B | — |
| NVCR | NovoCure Ltd | $1.77B | — |
| UFPT | UFP TECHNOLOGIES INC | $1.97B | 29.2 |
| BVS | Bioventus Inc. | $904.2M | 39.8 |
| ATRC | AtriCure, Inc. | $2.08B | — |
| Heartflow, Inc. |
| $2.16B |
| — |